Company Profile (obtained from Marketwatch): Ameriprise Financial, Inc. operates as a holding company. The company provides financial planning, asset management and insurance services to individuals, businesses and institutions. It operates through five segments: Advice & Wealth Management; Asset Management; Annuities; Protection; and Corporate & Other. The Advice & Wealth Management segment provides financial planning and advice, as well as full service brokerage and banking services, primarily to retail clients through the company’s financial advisors. The Asset Management segment provides investment advice and investment products to retail and institutional clients. It also provides products and services on a global scale through two complementary asset management businesses: Columbia Management and Threadneedle. The Columbia Management business primarily provides U.S. domestic products and services and Threadneedle primarily provides international investment products and services. Its international retail products are primarily provided through third-party financial institutions. The segments retail products include mutual funds and variable product funds underlying insurance and annuity separate accounts. The Annuities segment provides variable and fixed annuity products of RiverSource Life companies to retail clients. The Protection segment offers a variety of protection products to address the protection and risk management needs of the company’s retail clients, including life, DI, and property-casualty insurance. The Corporate & Other segment consists of net investment income on corporate level assets, including excess capital held in the company’s subsidiaries and other unallocated equity and other revenues from various investments as well as unallocated corporate expenses. Ameriprise Financial was founded by John Tappan in 1983 and is headquartered in Minneapolis, MN.
Downloadable PDF version of this valuation:
ModernGraham Valuation of AMP – March 2018
Stage 1: Is this company suitable for the Defensive Investor or the Enterprising Investor?
What kind of Intelligent Investor are you?
| Defensive Investor; must pass all 6 of the following tests. | ||||
| 1. Adequate Size of the Enterprise | Market Cap > $2Bil | $23,253,648,372 | Pass | |
| 2. Earnings Stability | Positive EPS for 10 years prior | Pass | ||
| 3. Dividend Record | Dividend Payments for 10 years prior | Pass | ||
| 4. Earnings Growth | Increase of 33% in EPS in past 10 years using 3 year averages at beginning and end | 169.30% | Pass | |
| 5. Moderate PEmg Ratio | PEmg < 20 | 15.16 | Pass | |
| 6. Moderate Price to Assets | PB Ratio < 2.5 OR PB*PEmg < 50 | 4.08 | Fail | |
| Enterprising Investor; must pass all 3 of the following tests, or be suitable for the Defensive Investor. | ||||
| 1. Earnings Stability | Positive EPS for 5 years prior | Pass | ||
| 2. Dividend Record | Currently Pays Dividend | Pass | ||
| 3. Earnings Growth | EPSmg greater than 5 years ago | Pass | ||
Stage 2: Determination of Intrinsic Value
| EPSmg | $10.48 |
| MG Growth Estimate | 9.99% |
| MG Value | $298.46 |
| Opinion | Undervalued |
| MG Grade | B |
| MG Value based on 3% Growth | $151.96 |
| MG Value based on 0% Growth | $89.08 |
| Market Implied Growth Rate | 3.33% |
| Current Price | $158.91 |
| % of Intrinsic Value | 53.24% |
Ameriprise Financial, Inc. is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the high PB ratio. The Enterprising Investor has no initial concerns. As a result, all Enterprising Investors following the ModernGraham approach should feel comfortable proceeding with the analysis.
As for a valuation, the company appears to be Undervalued after growing its EPSmg (normalized earnings) from $6.29 in 2014 to an estimated $10.48 for 2018. This level of demonstrated earnings growth outpaces the market’s implied estimate of 3.33% annual earnings growth over the next 7-10 years. As a result, the ModernGraham valuation model, based on Benjamin Graham’s formula, returns an estimate of intrinsic value above the price.
At the time of valuation, further research into Ameriprise Financial, Inc. revealed the company was trading above its Graham Number of $114.12. The company pays a dividend of $3.24 per share, for a yield of 2% Its PEmg (price over earnings per share – ModernGraham) was 15.16, which was below the industry average of 25.5, which by some methods of valuation makes it one of the most undervalued stocks in its industry.
Ameriprise Financial, Inc. performs fairly well in the ModernGraham grading system, scoring a B.
Stage 3: Information for Further Research
| Graham Number | $114.12 |
| PEmg | 15.16 |
| PB Ratio | 4.08 |
| Dividend Yield | 2.04% |
| TTM Dividend | $3.24 |
| Number of Consecutive Years of Dividend Growth | 13 |
Useful Links:
| ModernGraham tagged articles | Morningstar |
| Google Finance | MSN Money |
| Yahoo Finance | Seeking Alpha |
| GuruFocus | SEC Filings |
Most Recent Balance Sheet Figures
| Balance Sheet Information | 12/1/2017 |
| Long-Term Debt & Capital Lease Obligation | $5,099,000,000 |
| Total Assets | $147,470,000,000 |
| Intangible Assets | $0 |
| Total Liabilities | $141,472,000,000 |
| Shares Outstanding (Diluted Average) | 154,000,000 |
Earnings Per Share History
| EPS History | |
| Next Fiscal Year Estimate | $14.15 |
| Dec2017 | $9.44 |
| Dec2016 | $7.81 |
| Dec2015 | $8.48 |
| Dec2014 | $8.30 |
| Dec2013 | $6.44 |
| Dec2012 | $4.62 |
| Dec2011 | $4.53 |
| Dec2010 | $4.18 |
| Dec2009 | $2.95 |
| Dec2008 | -$0.16 |
| Dec2007 | $3.39 |
| Dec2006 | $2.54 |
| Dec2005 | $2.32 |
| Dec2004 | $3.22 |
| Dec2003 | $2.95 |
Earnings Per Share – ModernGraham History
| EPSmg History | |
| Next Fiscal Year Estimate | $10.48 |
| Dec2017 | $8.46 |
| Dec2016 | $7.69 |
| Dec2015 | $7.25 |
| Dec2014 | $6.29 |
| Dec2013 | $5.04 |
| Dec2012 | $3.97 |
| Dec2011 | $3.42 |
| Dec2010 | $2.77 |
| Dec2009 | $2.11 |
| Dec2008 | $1.88 |
| Dec2007 | $2.90 |
| Dec2006 | $2.50 |
| Dec2005 | $2.22 |
| Dec2004 | $1.86 |
| Dec2003 | $0.98 |
Recommended Reading:
Other ModernGraham posts about the company
Other ModernGraham posts about related companies
Disclaimer:
The author did not hold a position in any company mentioned in this article at the time of publication and had no intention of changing that position within the next 72 hours.  See my current holdings here.  This article is not investment advice; any reader should speak to a registered investment adviser prior to making any investment decisions.  ModernGraham is not affiliated with the company in any manner.  Please be sure to review our detailed disclaimer.
Leave a Reply